Drug Interactions between cholestyramine and Copegus
This report displays the potential drug interactions for the following 2 drugs:
- cholestyramine
- Copegus (ribavirin)
Interactions between your drugs
No interactions were found between cholestyramine and Copegus. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
cholestyramine
A total of 134 drugs are known to interact with cholestyramine.
- Cholestyramine is in the drug class bile acid sequestrants.
-
Cholestyramine is used to treat the following conditions:
- Crohn's Disease (off-label)
- Dumping Syndrome (off-label)
- High Cholesterol
- Hyperlipoproteinemia
- Hyperlipoproteinemia Type IIa, Elevated LDL
- Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
- Irritable Bowel Syndrome (off-label)
- Post-Cholecystectomy Diarrhea (off-label)
- Pruritus of Partial Biliary Obstruction
Copegus
A total of 18 drugs are known to interact with Copegus.
- Copegus is in the following drug classes: inhaled anti-infectives, purine nucleosides.
- Copegus is used to treat Hepatitis C.
Drug and food interactions
ribavirin food
Applies to: Copegus (ribavirin)
Food can enhance the levels of ribavirin in your body. Ribavirin should be taken with food or just after eating. This will make it easier for your body to absorb the medication. Do not take it on an empty stomach. Swallow the tablet or capsule whole.
cholestyramine food
Applies to: cholestyramine
Using cholestyramine together with multivitamin with minerals may decrease the effects of multivitamin with minerals. Multivitamin with minerals should be administered at least 4 hours before cholestyramine. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.